Jove
Visualize
  1. Home
  2. Research Domains
  3. Engineering
  4. Electrical Engineering
  5. Electrical Energy Generation (incl. Renewables, Excl. Photovoltaics)
  6. [myocardial Dysfunction Secondary To Persistent Tachycardia]

[Myocardial dysfunction secondary to persistent tachycardia]

D T Hachul, E A Sosa, M Barbero-Marcial

Arquivos Brasileiros De Cardiologia|December 1, 1989

View abstract on PubMed

Summary

Incessant atrioventricular tachycardia (IAVT) can cause reversible ventricular dysfunction. Surgical ablation of the anomalous pathway effectively restored normal heart function and eliminated tachycardia in patients refractory to medication.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Surgery

Context:

  • Incessant atrioventricular tachycardia (IAVT) is a rare arrhythmia.
  • Patients with IAVT often present with ventricular dysfunction.
  • Drug-refractory IAVT poses a significant clinical challenge.

Purpose:

  • To evaluate the impact of surgical ablation on ventricular dysfunction in patients with IAVT.
  • To assess the efficacy of surgical intervention in managing drug-refractory IAVT.
  • To demonstrate the reversibility of myocardial dysfunction following successful arrhythmia ablation.

Summary:

  • This study investigated five patients with IAVT and ventricular dysfunction who underwent surgical ablation.
  • Preoperative assessments revealed persistent tachycardia, impaired ejection fraction, and enlarged left ventricular diastolic diameter.
  • Electrophysiologic study identified a postero-septal anomalous atrioventricular pathway.
  • Post-ablation, all patients achieved asymptomatic sinus rhythm with significant improvement in ejection fraction and normalization of ventricular dimensions.

Impact:

  • Surgical ablation of anomalous atrioventricular pathways is a highly effective treatment for IAVT.
  • Myocardial dysfunction associated with IAVT is reversible after successful ablation.
  • This intervention offers a definitive solution for patients refractory to antiarrhythmic drugs.
footer-logo
x-logofacebook-logolinkedin-logowechat-logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site

Terms & Conditions of Use
Privacy Policy
Policies